David Ofori‐Adjei

MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity

Margaret‐Mary Ameyaw, Fernando Regateiro, Tao Li et al. · Pharmacogenetics · 2001 · 411 citations

Medicine, Molecular Genetics, Pharmacology +15

Field tests for rational drug use in twelve developing countries

HV Hogerzeil, Bimo, Dennis Ross‐Degnan et al. · The Lancet · 1993 · 329 citations

Pharmacy, Pharmacology, Pharmaceutical Compliance +2

Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.

Katherine A. McGlynn, Elizabeth Rosvold, Edward D. Lustbader et al. · Proceedings of the National Academy of Sciences · 1995 · 276 citations

Medicine, Genetics, Molecular Genetics +17

Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of <i>Mycobacterium ulcerans</i> in Early Lesions of Buruli Ulcer in Humans

Samuel Etuaful, B Carbonnelle, J Grosset et al. · Antimicrobial Agents and Chemotherapy · 2005 · 244 citations

Life Sciences, Dermatology, Microbiology +16

Risk Factors for Buruli Ulcer Disease (Mycobacterium ulcerans Infection): Results from a Case-Control Study in Ghana

Pratima L. Raghunathan, Ellen A. Spotts Whitney, Kwame Asamoa et al. · Clinical Infectious Diseases · 2005 · 159 citations · Full text

Life Sciences, Dermatology, Infectious Diseases +16